SMARCC2 and renal cell carcinoma: CCK8 assay results revealed that the inhibitory effect of shTRIM37 on RCC cell proliferation was significantly counteracted by SMARCC2 silencing, while SMARCC2 overexpression attenuated the growth induced by TRIM37 overexpression (Fig. 7a).